BiotechTube
Home/Aegle Therapeutics/Evangelos V. Badiavas
EV

Evangelos V. Badiavas

Scientific Founder/Key Researcher

Aegle Therapeutics

Therapeutic Areas

Rare Dermatological DiseasesRegenerative Medicine

Aegle Therapeutics Pipeline

DrugIndicationPhase
AGLE-102Recessive Dystrophic Epidermolysis Bullosa (RDEB)Phase 1/2